Dedicated to the discovery & development of antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic & pandemic threats.
Location: Switzerland, Vaud, Lausanne
Investors 2
| Date | Name | Website |
| 19.04.2022 | Omega Fund... | omegafunds... |
| - | F-Prime Ca... | fprimecapi... |
Mentions in press and media 2
| Date | Title | Description |
| 06.10.2023 | Aerium Therapeutics begins development of three in-licensed antibodies | |
| 28.03.2022 | Aerium Therapeutics emerges from stealth mode with substantial Series A funding |